Iron: The hard player in diabetes pathophysiology

Acta Physiologica

Volumn 210, Issue 4, 2014, Pages 717-732

  Hansen, J B ^a,b   Moen, I W ^a   Mandrup Poulsen, T ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF TORONTO   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Inflammation; Iron transport; Mitochondrial stress; Oxidative stress; Reactive oxygen species; cell

Indexed keywords

ADENOSINE PHOSPHATE; FERROUS ION; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DEDIFFERENTIATION; FERROPTOSIS; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INTERVENTION STUDY; IRON CHELATION; IRON INTAKE; IRON METABOLISM DISORDER; IRON OVERLOAD; IRON TRANSPORT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SAFETY; THERAPY EFFECT;

INFLAMMATION; IRON TRANSPORT; MITOCHONDRIAL STRESS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; Β-CELL;

BIOLOGICAL TRANSPORT; DIABETES MELLITUS; HUMANS; INSULIN-SECRETING CELLS; IRON; IRON, DIETARY;

EID: 84896032718     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12256     Document Type: Article

References (106)

1. Aigner, E., Felder, T.K., Oberkofler, H., Hahne, P., Auer, S., Soyal, S., Stadlmayr, A., Schwenoha, K., Pirich, C., Hengster, P., Datz, C. & Patsch, W. 2013. Glucose acts as a regulator of serum iron by increasing serum hepcidin concentrations. J Nutr Biochem 24, 112-117.
2. Ammendrup, A., Maillard, A., Nielsen, K., Aabenhus Andersen, N., Serup, P., Dragsbaek Madsen, O., Mandrup-Poulsen, T. & Bonny, C. 2000. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic beta-cells. Diabetes 49, 1468-1476.
3. Andrews, N.C. & Schmidt, P.J. 2007. Iron homeostasis. Annu Rev Physiol 69, 69-85.
4. Azevedo-Martins, A.K., Lortz, S., Lenzen, S., Curi, R., Eizirik, D.L. & Tiedge, M. 2003. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes 52, 93-101.
5. Bowers, K., Yeung, E., Williams, M.A., Qi, L., Tobias, D.K., Hu, F.B. & Zhang, C. 2011. A prospective study of prepregnancy dietary iron intake and risk for gestational diabetes mellitus. Diabetes Care 34, 1557-1563.
6. Chen, J., Marks, E., Lai, B., Zhang, Z., Duce, J.A., Lam, L.Q., Volitakis, I., Bush, A.I., Hersch, S. & Fox, J.H. 2013. Iron accumulates in Huntington's disease neurons: protection by deferoxamine. PLoS One 8, e77023.
7. Cnop, M., Igoillo-Esteve, M., Hughes, S.J., Walker, J.N., Cnop, I. & Clark, A. 2011. Longevity of human islet alpha- and beta-cells. Diabetes Obes Metab 13(Suppl 1), 39-46.
8. Conlan, A.R., Axelrod, H.L., Cohen, A.E., Abresch, E.C., Zuris, J., Yee, D., Nechushtai, R., Jennings, P.A. & Paddock, M.L. 2009. Crystal structure of Miner1: the redox-active 2Fe-2S protein causative in Wolfram Syndrome 2. J Mol Biol 392, 143-153.
9. Cooksey, R.C., Jouihan, H.A., Ajioka, R.S., Hazel, M.W., Jones, D.L., Kushner, J.P. & McClain, D.A. 2004. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145, 5305-5312.
10. Cooksey, R.C., Jones, D., Gabrielsen, S., Huang, J., Simcox, J.A., Luo, B., Soesanto, Y., Rienhoff, H., Abel, E.D. & McClain, D.A. 2010. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab 298, E1236-E1243.
11. Correnti, C. & Strong, R.K. 2012. Mammalian siderophores, siderophore-binding lipocalins, and the labile iron pool. J Biol Chem 287, 13524-13531.
12. Cutler, P. 1989. Deferoxamine therapy in high-ferritin diabetes. Diabetes 38, 1207-1210.
13. Danial, N.N., Walensky, L.D., Zhang, C.Y., Choi, C.S., Fisher, J.K., Molina, A.J., Datta, S.R., Pitter, K.L., Bird, G.H., Wikstrom, J.D. et al. 2008. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat Med 14, 144-153.
14. Delatycki, M.B. & Corben, L.A. 2012. Clinical features of Friedreich ataxia. J Child Neurol 27, 1133-1137.
15. Devireddy, L.R., Hart, D.O., Goetz, D.H. & Green, M.R. 2010. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 141, 1006-1017.
16. Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., Morrison, B. 3rd & Stockwell, B.R. 2012. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072.
17. Donovan, A., Lima, C.A., Pinkus, J.L., Pinkus, G.S., Zon, L.I., Robine, S. & Andrews, N.C. 2005. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1, 191-200.
18. Dubois-Laforgue, D., Caillat-Zucman, S., Boitard, C. & Timsit, J. 2000. Clinical characteristics of type 2 diabetes in patients with mutations of HFE. Diabetes Metab 26, 65-68.
19. Dusek, P., Jankovic, J. & Le, W. 2012. Iron dysregulation in movement disorders. Neurobiol Dis 46, 1-18.
20. Eaton, J.W. & Qian, M. 2002. Molecular bases of cellular iron toxicity. Free Radic Biol Med 32, 833-840.
21. Eldor, R., Yeffet, A., Baum, K., Doviner, V., Amar, D., Ben-Neriah, Y., Christofori, G., Peled, A., Carel, J.C., Boitard, C., Klein, T., Serup, P., Eizirik, D.L. & Melloul, D. 2006. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci USA 103, 5072-5077.
22. Ellervik, C., Mandrup-Poulsen, T., Nordestgaard, B.G., Larsen, L.E., Appleyard, M., Frandsen, M., Petersen, P., Schlichting, P., Saermark, T., Tybjaerg-Hansen, A. & Birgens, H. 2001. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 358, 1405-1409.
23. Ellervik, C., Mandrup-Poulsen, T., Andersen, H.U., Tybjaerg-Hansen, A., Frandsen, M., Birgens, H. & Nordestgaard, B.G. 2011. Elevated transferrin saturation and risk of diabetes: three population-based studies. Diabetes Care 34, 2256-2258.
24. Elouil, H., Cardozo, A.K., Eizirik, D.L., Henquin, J.C. & Jonas, J.C. 2005. High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFkappaB. Diabetologia 48, 496-505.
25. Evstatiev, R. & Gasche, C. 2012. Iron sensing and signalling. Gut 61, 933-952.
26. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., Dormishian, F., Domingo, R. Jr, Ellis, M.C., Fullan, A. et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13, 399-408.
27. Fernandez-Real, J.M., Penarroja, G., Castro, A., Garcia-Bragado, F., Hernandez-Aguado, I. & Ricart, W. 2002. Bloodletting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes 51, 1000-1004.
28. Ford, E.S. & Cogswell, M.E. 1999. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 22, 1978-1983.
29. Fu, J., Zhang, Q., Woods, C.G., Zheng, H., Yang, B., Qu, W., Andersen, M.E. & Pi, J. 2013. Divergent effects of sulforaphane on basal and glucose-stimulated insulin secretion in beta-cells: role of reactive oxygen species and induction of endogenous antioxidants. Pharm Res 30, 2248-2259.
30. Fuentes, M., Andrews, M. & Arredondo-Olguin, M. 2013. Effects of high iron and glucose concentrations over the relative expression of Bcl2, Bax, and Mfn2 in MIN6 cells. Biol Trace Elem Res 153, 390-395.
31. Gabrielsen, J.S., Gao, Y., Simcox, J.A., Huang, J., Thorup, D., Jones, D., Cooksey, R.C., Gabrielsen, D., Adams, T.D., Hunt, S.C., Hopkins, P.N., Cefalu, W.T. & McClain, D.A. 2012. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 122, 3529-3540.
32. Gkouvatsos, K., Papanikolaou, G. & Pantopoulos, K. 2012. Regulation of iron transport and the role of transferrin. Biochim Biophys Acta 1820, 188-202.
33. Golbidi, S., Ebadi, S.A. & Laher, I. 2011. Antioxidants in the treatment of diabetes. Curr Diabetes Rev 7, 106-125.
34. Gunshin, H., Mackenzie, B., Berger, U.V., Gunshin, Y., Romero, M.F., Boron, W.F., Nussberger, S., Gollan, J.L. & Hediger, M.A. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488.
35. Gunshin, H., Fujiwara, Y., Custodio, A.O., Direnzo, C., Robine, S. & Andrews, N.C. 2005. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest 115, 1258-1266.
36. Gurgul-Convey, E., Mehmeti, I., Lortz, S. & Lenzen, S. 2011. Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria. J Mol Med (Berl) 89, 785-798.
37. Hansen, J.B., Tonnesen, M.F., Madsen, A.N., Hagedorn, P.H., Friberg, J., Grunnet, L.G., Heller, R.S., Nielsen, A.O., Storling, J., Baeyens, L. et al. 2012. Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic beta cell fate in response to cytokines. Cell Metab 16, 449-461.
38. Hare, D., Ayton, S., Bush, A. & Lei, P. 2013. A delicate balance: iron metabolism and diseases of the brain. Front Aging Neurosci 5, 34.
39. Hirsch, E.C. 2009. Iron transport in Parkinson's disease. Parkinsonism Relat Disord 15(Suppl 3), S209-S211.
40. Huang, J., Jones, D., Luo, B., Sanderson, M., Soto, J., Abel, E.D., Cooksey, R.C. & McClain, D.A. 2011. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes 60, 80-87.
41. Huang, J., Simcox, J., Mitchell, T.C., Jones, D., Cox, J., Luo, B., Cooksey, R.C., Boros, L.G. & McClain, D.A. 2013. Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice. FASEB J 27, 2845-2854.
42. Imai, Y., Dobrian, A.D., Morris, M.A. & Nadler, J.L. 2013. Islet inflammation: a unifying target for diabetes treatment? Trends Endocrinol Metab 24, 351-360.
43. Jehn, M., Clark, J.M. & Guallar, E. 2004. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 27, 2422-2428.
44. Jiang, R., Manson, J.E., Meigs, J.B., Ma, J., Rifai, N. & Hu, F.B. 2004. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291, 711-717.
45. Jorns, A., Arndt, T., Zu Vilsendorf, A.M., Klempnauer, J., Wedekind, D., Hedrich, H.J., Marselli, L., Marchetti, P., Harada, N., Nakaya, Y., Wang, G.S., Scott, F.W., Gysemans, C., Mathieu, C. & Lenzen, S. 2013. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia 57, 512-521.
46. Jouihan, H.A., Cobine, P.A., Cooksey, R.C., Hoagland, E.A., Boudina, S., Abel, E.D., Winge, D.R. & McClain, D.A. 2008. Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol Med 14, 98-108.
47. Kakhlon, O. & Cabantchik, Z.I. 2002. The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med 33, 1037-1046.
48. Kaneto, H., Katakami, N., Matsuhisa, M. & Matsuoka, T.A. 2010. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010, 453892.
49. Kartikasari, A.E., Visseren, F.L., Marx, J.J., van Mullekom, S., Kats-Renaud, J.H., Asbeck, B.S., Ulfman, L.H. & Georgiou, N.A. 2009. Intracellular labile iron promotes firm adhesion of human monocytes to endothelium under flow and transendothelial migration: iron and monocyte-endothelial cell interactions. Atherosclerosis 205, 369-375.
50. Kaye, T.B., Guay, A.T. & Simonson, D.C. 1993. Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 7, 246-249.
51. Kim, W.H., Lee, J.W., Gao, B. & Jung, M.H. 2005. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal 17, 1516-1532.
52. Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W.H. 3rd, Wright, C.V., White, M.F., Arden, K.C. & Accili, D. 2002. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110, 1839-1847.
53. Koch, R.O., Zoller, H., Theuri, I., Obrist, P., Egg, G., Strohmayer, W., Vogel, W. & Weiss, G. 2003. Distribution of DMT 1 within the human glandular system. Histol Histopathol 18, 1095-1101.
54. Kulaksiz, H., Fein, E., Redecker, P., Stremmel, W., Adler, G. & Cetin, Y. 2008. Pancreatic beta-cells express hepcidin, an iron-uptake regulatory peptide. J Endocrinol 197, 241-249.
55. Kusminski, C.M., Holland, W.L., Sun, K., Park, J., Spurgin, S.B., Lin, Y., Askew, G.R., Simcox, J.A., McClain, D.A., Li, C. & Scherer, P.E. 2012. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 18, 1539-1549.
56. Leloup, C., Tourrel-Cuzin, C., Magnan, C., Karaca, M., Castel, J., Carneiro, L., Colombani, A.L., Ktorza, A., Casteilla, L. & Penicaud, L. 2009. Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion. Diabetes 58, 673-681.
57. Lenzen, S. 2008. Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 36, 343-347.
58. Li, X., Chen, H. & Epstein, P.N. 2006. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells. Diabetes 55, 1592-1604.
59. Li, N., Li, B., Brun, T., Deffert-Delbouille, C., Mahiout, Z., Daali, Y., Ma, X.J., Krause, K.H. & Maechler, P. 2012. NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion. Diabetes 61, 2842-2850.
60. Lortz, S., Gurgul-Convey, E., Naujok, O. & Lenzen, S. 2013. Overexpression of the antioxidant enzyme catalase does not interfere with the glucose responsiveness of insulin-secreting INS-1E cells and rat islets. Diabetologia 56, 774-782.
61. Ma, Z.A., Zhao, Z. & Turk, J. 2012. Mitochondrial dysfunction and beta-cell failure in type 2 diabetes mellitus. Exp Diabetes Res 2012, 703538.
62. MacDonald, M.J., Cook, J.D., Epstein, M.L. & Flowers, C.H. 1994. Large amount of (apo)ferritin in the pancreatic insulin cell and its stimulation by glucose. FASEB J 8, 777-781.
63. Mackenzie, B. & Hediger, M.A. 2004. SLC11 family of H + -coupled metal-ion transporters NRAMP1 and DMT1. Pflugers Arch 447, 571-579.
64. Mackenzie, B., Ujwal, M.L., Chang, M.H., Romero, M.F. & Hediger, M.A. 2006. Divalent metal-ion transporter DMT1 mediates both H + -coupled Fe2 + transport and uncoupled fluxes. Pflugers Arch 451, 544-558.
65. McClain, D.A., Abraham, D., Rogers, J., Brady, R., Gault, P., Ajioka, R. & Kushner, J.P. 2006. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 49, 1661-1669.
66. Mechlovich, D., Amit, T., Mandel, S.A., Bar-Am, O., Bloch, K., Vardi, P. & Youdim, M.B. 2010. The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage. J Pharmacol Exp Ther 333, 874-882.
67. Meur, G., Qian, Q., da Silva Xavier, G., Pullen, T.J., Tsuboi, T., McKinnon, C., Fletcher, L., Tavare, J.M., Hughes, S., Johnson, P. & Rutter, G.A. 2011. Nucleo-cytosolic shuttling of FoxO1 directly regulates mouse Ins2 but not Ins1 gene expression in pancreatic beta cells (MIN6). J Biol Chem 286, 13647-13656.
68. Minamiyama, Y., Takemura, S., Kodai, S., Shinkawa, H., Tsukioka, T., Ichikawa, H., Naito, Y., Yoshikawa, T. & Okada, S. 2010. Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 298, E1140-E1149.
69. Mojiminiyi, O.A., Marouf, R. & Abdella, N.A. 2008. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 18, 559-566.
70. Montonen, J., Boeing, H., Steffen, A., Lehmann, R., Fritsche, A., Joost, H.G., Schulze, M.B. & Pischon, T. 2012. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia 55, 2613-2621.
71. Morgan, D., Rebelato, E., Abdulkader, F., Graciano, M.F., Oliveira-Emilio, H.R., Hirata, A.E., Rocha, M.S., Bordin, S., Curi, R. & Carpinelli, A.R. 2009. Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells. Endocrinology 150, 2197-2201.
72. Namgaladze, D., Hofer, H.W. & Ullrich, V. 2002. Redox control of calcineurin by targeting the binuclear Fe(2 + )-Zn(2 + ) center at the enzyme active site. J Biol Chem 277, 5962-5969.
73. Nielsen, J.H. 1989. Mechanisms of pancreatic beta-cell growth and regeneration: studies on rat insulinoma cells. Exp Clin Endocrinol 93, 277-285.
74. Nino Fong, R., Fatehi-Hassanabad, Z., Lee, S.C., Lu, H., Wheeler, M.B. & Chan, C.B. 2011. Uncoupling protein-2 increases nitric oxide production and TNFAIP3 pathway activation in pancreatic islets. J Mol Endocrinol 46, 193-204.
75. Noormets, K., Koks, S., Muldmaa, M., Mauring, L., Vasar, E. & Tillmann, V. 2011. Sex differences in the development of diabetes in mice with deleted wolframin (Wfs1) gene. Exp Clin Endocrinol Diabetes 119, 271-275.
76. Orr, J.S., Kennedy, A., Anderson-Baucum, E.K., Webb, C.D., Fordahl, S.C., Erikson, K.M., Zhang, Y., Etzerodt, A., Moestrup, S.K. & Hasty, A.H. 2013. Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes 63, 421-432.
77. Papanikolaou, G. & Pantopoulos, K. 2005. Iron metabolism and toxicity. Toxicol Appl Pharmacol 202, 199-211.
78. Philpott, C.C. 2012. Coming into view: eukaryotic iron chaperones and intracellular iron delivery. J Biol Chem 287, 13518-13523.
79. Pollak, Y., Mechlovich, D., Amit, T., Bar-Am, O., Manov, I., Mandel, S.A., Weinreb, O., Meyron-Holtz, E.G., Iancu, T.C. & Youdim, M.B. 2013. Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism. J Neural Transm 120, 37-48.
80. Polson, R.J., Jenkins, R., Lombard, M., Williams, A.C., Roberts, S., Nouri-Aria, K., Williams, R. & Bomford, A. 1990. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology 71, 176-181.
81. Ponugoti, B., Dong, G. & Graves, D.T. 2012. Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp Diabetes Res 2012, 939751.
82. Pra, D., Franke, S.I., Henriques, J.A. & Fenech, M. 2012. Iron and genome stability: an update. Mutat Res 733, 92-99.
83. Qiao, B., Sugianto, P., Fung, E., Del-Castillo-Rueda, A., Moran-Jimenez, M.J., Ganz, T. & Nemeth, E. 2012. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 15, 918-924.
84. Rajpathak, S.N., Crandall, J.P., Wylie-Rosett, J., Kabat, G.C., Rohan, T.E. & Hu, F.B. 2009. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 1790, 671-681.
85. Redmon, J.B., Pyzdrowski, K.L. & Robertson, R.P. 1993. No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin. Diabetes 42, 544-549.
86. Richardson, D.R., Lane, D.J., Becker, E.M., Huang, M.L., Whitnall, M., Suryo Rahmanto, Y., Sheftel, A.D. & Ponka, P. 2010. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci USA 107, 10775-10782.
87. Robson-Doucette, C.A., Sultan, S., Allister, E.M., Wikstrom, J.D., Koshkin, V., Bhattacharjee, A., Prentice, K.J., Sereda, S.B., Shirihai, O.S. & Wheeler, M.B. 2011. Beta-cell uncoupling protein 2 regulates reactive oxygen species production, which influences both insulin and glucagon secretion. Diabetes 60, 2710-2719.
88. Salonen, J.T., Tuomainen, T.P. & Kontula, K. 2000. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. BMJ 320, 1706-1707.
89. Scott, J.A. & King, G.L. 2004. Oxidative stress and antioxidant treatment in diabetes. Ann N Y Acad Sci 1031, 204-213.
90. Setsukinai, K., Urano, Y., Kakinuma, K., Majima, H.J. & Nagano, T. 2003. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278, 3170-3175.
91. Sheftel, A.D., Mason, A.B. & Ponka, P. 2012. The long history of iron in the Universe and in health and disease. Biochim Biophys Acta 1820, 161-187.
92. da Silva Xavier, G., Leclerc, I., Varadi, A., Tsuboi, T., Moule, S.K. & Rutter, G.A. 2003. Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem J 371, 761-774.
93. Sohn, Y.S., Tamir, S., Song, L., Michaeli, D., Matouk, I., Conlan, A.R., Harir, Y., Holt, S.H., Shulaev, V., Paddock, M.L. et al. 2013. NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth. Proc Natl Acad Sci USA 110, 14676-14681.
94. Stokes, R.A., Cheng, K., Deters, N., Lau, S.M., Hawthorne, W.J., O'Connell, P.J., Stolp, J., Grey, S., Loudovaris, T., Kay, T.W., Thomas, H.E., Gonzalez, F.J. & Gunton, J.E. 2013. Hypoxia-inducible factor-1alpha (HIF-1alpha) potentiates beta-cell survival after islet transplantation of human and mouse islets. Cell Transplant 22, 253-266.
95. Tajima, S., Ikeda, Y., Sawada, K., Yamano, N., Horinouchi, Y., Kihira, Y., Ishizawa, K., Izawa-Ishizawa, Y., Kawazoe, K., Tomita, S., Minakuchi, K., Tsuchiya, K. & Tamaki, T. 2012. Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab 302, E77-E86.
96. Thomas, M.C., MacIsaac, R.J., Tsalamandris, C. & Jerums, G. 2004. Elevated iron indices in patients with diabetes. Diabet Med 21, 798-802.
97. Tranebjaerg, L., Barrett, T. & Rendtorff, N.D. 1993. WFS1-related disorders. In: R.A. Pagon, M.P. Adam, T.D. Bird, C.R. Dolan, C.T. Fong & K. Stephens (eds) GeneReviews, Seattle, WA.
98. Utzschneider, K.M. & Kowdley, K.V. 2010. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol 6, 26-33.
99. Vaithilingam, V., Oberholzer, J., Guillemin, G.J. & Tuch, B.E. 2010. Beneficial effects of desferrioxamine on encapsulated human islets-in vitro and in vivo study. Am J Transplant 10, 1961-1969.
100. Verga Falzacappa, M.V. & Muckenthaler, M.U. 2005. Hepcidin: iron-hormone and anti-microbial peptide. Gene 364, 37-44.
101. Wang, Y., Wu, M., Al-Rousan, R., Liu, H., Fannin, J., Paturi, S., Arvapalli, R.K., Katta, A., Kakarla, S.K., Rice, K.M., Triest, W.E. & Blough, E.R. 2011. Iron-induced cardiac damage: role of apoptosis and deferasirox intervention. J Pharmacol Exp Ther 336, 56-63.
102. Whitley, W.D., Hancock, W.W., Kupiec-Weglinski, J.W., DeSousa, M. & Tilney, N.L. 1993. Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats. Transplantation 56, 1182-1188.
103. Wiley, S.E., Murphy, A.N., Ross, S.A., van der Geer, P. & Dixon, J.E. 2007. MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc Natl Acad Sci USA 104, 5318-5323.
104. Wiley, S.E., Andreyev, A.Y., Divakaruni, A.S., Karisch, R., Perkins, G., Wall, E.A., van der Geer, P., Chen, Y.F., Tsai, T.F., Simon, M.I., Neel, B.G., Dixon, J.E. & Murphy, A.N. 2013. Wolfram Syndrome protein, Miner1, regulates sulphydryl redox status, the unfolded protein response, and Ca2 + homeostasis. EMBO Mol Med 5, 904-918.
105. Wilson, J.G., Lindquist, J.H., Grambow, S.C., Crook, E.D. & Maher, J.F. 2003. Potential role of increased iron stores in diabetes. Am J Med Sci 325, 332-339.
106. Xu, G., Ahn, J., Chang, S., Eguchi, M., Ogier, A., Han, S., Park, Y., Shim, C., Jang, Y., Yang, B., Xu, A., Wang, Y. & Sweeney, G. 2012. Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation. J Biol Chem 287, 4808-4817.